#pharmacokinetics — Friday, September 04, 2026 (1 items)
| 0 | ℹ |
Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-09-04 | #pharmacokinetics #clinical trial #hiv #antiviral #drug safety |